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Abstract
AIM: To establish the roles of lipopolysaccharide 
(LPS)/CD14/toll-like receptor 4 (TLR4)-mediated 
inflammation in a rat model of human necrotizing 
enterocolitis (NEC). 
METHODS: Six pairs of intestinal samples from 
human NEC were collected before and after recovery 
for histological and molecular analysis of inflammatory 
cytokines and signaling components. In the rat NEC 
model, we isolated 10-cm jejunum segments and 
divided them into six groups (n  = 6) for sham operation, 
treatment with LPS, bowel distension, combined bowel 
distension and LPS stimulation, and two therapeutic 
groups. The potential efficacy of a recombinant CD18 
peptide and a monoclonal CD14 antibody was evaluated 
in the latter two groups. The serum and tissue levels 
of several inflammatory mediators were quantified 
by real-time polymerase chain reaction, ELISA and 
immunoblotting. 
RESULTS: Human acute phase NEC tissues displayed 
significant increases (P  < 0.05) in levels of TLR4, 
CD14, myeloid differentiation protein (MD)-2, tumor 
necrosis factor (TNF)-α and nuclear factor-κB when 
compared to those after recovery. The histological and 
inflammatory picture of human NEC was reproduced in 
rats that were treated with combined bowel distension 
and LPS, but not in the sham-operated and other 
control rats. Serum levels of interleukin-6 and TNF-α 
were also elevated. The NEC pathology was attenuated 
by treating the NEC rats with a monoclonal CD14 
antibody or an LPS-neutralizing peptide.
CONCLUSION: LPS and distension are required to 
produce the histological and inflammatory features 
of NEC. A potential treatment option is blocking LPS 
activation and leukocyte infiltration.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
Necrotizing enterocolitis (NEC) is a common gastro­
intestinal disorder in newborn and premature infants 
with a relatively high mortality rate (approximately 
30%), and requires emergency medical treatment[1]. 
While the molecular pathogenesis of  neonatal NEC 
is multifactorial and remains to be elucidated fully, its 
known risk factors include prematurity and low birth 
weight[1,2]. Ballance et al [3] have reviewed pathology 
specimens from a cohort of  84 neonatal NEC patients, 
and have reported that the most consistent features of  
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the disease are ischemic necrosis, inflammation, and 
bacterial overgrowth. Since neonatal NEC does not 
develop in utero in the sterile gut, bacterial contamination 
and/or microbial involvement have been implicated 
in its pathogenesis[4]. Furthermore, > 90% of  preterm 
infants who develop NEC have received enteral feeds[5], 
and there is an increased risk of  NEC when these infants 
are overfed frequently[6­9]. This could result in intestinal 
injury because of  impaired digestion of  nutrients, 
delayed transit time and bacterial overgrowth[10]. 
Based on these recent findings, we believe that there 
is a connection between host immunity and pathogenesis 
of  NEC, and the toll­like receptor (TLR)­mediated 
immunity apparently plays an important role. TLRs are 
evolutionarily conserved transmembrane molecules 
that help the immune system to recognize pathogen­
associated molecular patterns, and TLR4 sensitizes 
immune cells to bacterial lipopolysaccharide (LPS). 
When stimulated by bacterial LPS, many intracellular 
signaling pathways are activated, and lead to the 
generation of  nuclear factor (NF)­κB, which in turn 
promotes pro­inflammatory cytokine production and 
release[11]. Caplan et al[12] have reported upregulation of  
MD­2, one of  the bacterial LPS co­receptors, in patients 
with NEC. 
In overfed or food­intolerant neonates, bowel loops 
can become distended and filled with milk, and this 
creates a good nutritive medium for bacterial growth 
and colonization. We hypothesized that bacterial LPS or 
endotoxin from cultured bacteria can trigger inflammation 
in NEC. In order to validate this hypothesis, we studied 
the TLR4­mediated signaling in the jejunal tissue from 
a rat model of  human NEC, and then used the findings 
to design novel therapeutic agents for use in neonatal 
patients with NEC. In this model, we ligated the jejunum, 
and distended the ligated jejunum with bacterial LPS in 
order to induce the inflammatory reaction of  NEC. 
MATERIALS AND METHODS
Human tissues
Necrotic NEC intestinal tissues were collected from six 
human infants (two girls and four boys) with stage 3 
NEC, who underwent curative surgery at Queen Mary 
Hospital, Hong Kong. The mean gestational age of  these 
NEC patients was 30 wk (range: 25­32 wk), and their 
mean birth weight was 1.51 kg (range: 0.57­2.51 kg). 
NEC was diagnosed between 2 and 32 d after birth (mean: 
17 d). For comparison, intestinal tissues were collected 
during the recovery phase at the time of  ileostomy 
closure. After surgical resection, each intestinal tissue 
sample was divided into two: one was snap­frozen in 
liquid nitrogen for determination of  mRNA/protein 
levels, and the other was fixed in 10% buffered formalin 
for histological examination. 
Reagents
Bacterial LPS from Salmonella typhimurium was purchased 
from Sigma (St. Louis, MO, USA), and was used to 
prepare a 5 µg/mL LPS solution with endotoxin­free 
saline[13]. A polyclonal antibody for use as an antagonist 
against the CD14 antigen (M­20) was purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
The LPS­neutralizing peptide was prepared using our 
established procedures[14,15]. The protein content in each 
solution was determined using Lowry’s method[16]. 
Animals
One­month old Sprague­Dawley rats were obtained 
from the Association for Assessment and Accreditation 
of  Laboratory Animal Care International (AAALAC)­
accredited Laboratory Animal Unit of  the University 
of  Hong Kong (Pokfulam, Hong Kong). The rats were 
maintained in a pathogen­free facility with a 12­h light/
dark cycle at ambient temperature and in a controlled 
humidity environment. The rats had ad libitum access 
to sterilized animal chow and water. All experimental 
procedures were reviewed, approved, and conducted 
in accordance with the ethical guidelines set forth by 
the University’s Committee on Using Live Animals for 
Teaching and Research.
Experimental NEC model
The rat model of  human NEC was modified from our 
published model[17]. Before surgery, rats were fasted 
overnight, and anesthetized by intraperitoneal injection 
of  sodium pentobarbital (40 mg/kg body weight). Once 
anesthetized, the abdomen was opened by a midline 
incision, and a 10­cm segment of  the most proximal 
jejunum was isolated with its vascular pedicle intact. 
One end of  the segment was closed by ligation. An 
18-G angiocatheter was inserted and fixed to the other 
end. The angiocatheter was connected to an infusion set 
whose height was 100 cm above the operating table. 
Each control and experimental group comprised 
six animals. For the sham­operated control rats, the 
angiocatheters were closed for 3 h using a plug. For the 
rats treated with LPS alone, 2 mL of  5 µg/mL LPS 
solution was injected directly into the jejunal segment. To 
increase intraluminal bowel pressure, the jejunal segment 
was distended with sterile saline at a pressure of  100 cm 
H2O for 3 h in four groups of  rats. In two groups, the 
bowel was distended with sterile saline alone or combined 
with 5 µg/mL LPS. In the remaining two groups, the 
bowel was distended in an identical manner, and contained 
5 µg/mL bacterial LPS and 0.8 µg/mL CD14 antibody 
or 0.8 µg/mL CD18 peptide, which has LPS­neutralizing 
capacity. After 3 h bowel distension, the animals were 
killed humanely by an overdose of  sodium pentobarbital 
(100 mg/kg). Formalin­fixed and snap­frozen jejunal 
tissues were prepared for histological examination and 
determination of  mRNA/protein levels, respectively. 
Blood was also collected from the inferior vena cava of  
all rats for serum/plasma preparation, and stored at ­70℃ 
until use.
Assessment of NEC severity 
Sections (4 µm thick) of  the harvested jejunal tissues 
were prepared for hematoxylin and eosin (HE) staining 
and immunohistochemistry[18,19]. The severity of  NEC 
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was scored histologically on the appearance of  the 
intestine, using a modification of  the method that was 
described by Caplan et al[20]: 0, normal intestine; 1, mild 
hemorrhage; 2, moderate hemorrhage and necrosis; 3, 
severe hemorrhagic necrotic lesions with or without 
pneumatosis. The degree of  macrophage infiltration 
was determined following overnight incubation at 4℃ 
with a macrophage staining reagent (Dako, Glostrup, 
Denmark). The resulting images were reviewed with a 
Nikon epifluorescent upright microscope E600 (Nikon, 
Tokyo, Japan), and captured with 3­CCD color camera 
DC­330 (DAGE­MTI, Michigan City, IN, USA). 
Real-time polymerase chain reaction (PCR) 
Real­time PCR was employed to determine the relative 
expression levels of  CD14, TLR4 and MD­2 mRNA 
in human and rat jejunal tissues. First­strand cDNA 
was synthesized from extracted RNA from jejunal 
tissue[20], and amplifications were done using the Power 
SYBR Green PCR Master Mix (Invitrogen, Carlsbad, 
CA, USA) in an ABI PRISM 7700 sequence detector 
system (Applied Biosystems, Foster City, CA, USA)[21]. 
Normalization and comparison of  mRNA transcript 
levels between the groups were then performed, as 
described previously[22].
Immunoblotting of NF-κB p65 and tumor necrosis factor 
(TNF)-α in the intestine of NEC patients
The nuclear levels of  NF­κB p65 and TNF­α in the 
jejunal tissue of  NEC patients were detected by antibody 
against NF­κB p65 (Invitrogen) and TNF­α (Santa Cruz 
Biotechnology), as described previously[15].
Determination of serum pro-inflammatory cytokine 
levels
Serum TNF­α and interleukin (IL)­6 levels in the control, 
sham­operated, and treated rats were determined using 
commercially available ELISA kits that were purchased 
from Dakewe (Shenzhen, China) and eBioscience (San 
Diego, CA, USA), respectively, in accordance with the 
manufacturer’s instructions.
Statistical analysis
Statistical analyses of  the experimental data were 
performed using GraphPad Prism (version 4.0, GraphPad 
Software Inc, San Diego, CA, USA). Statistical significance 
was set at 5%, and data are presented as mean ± SD. 
RESULTS
Human NEC intestinal histology and inflammatory 
pathology
Serial samples of  intestinal tissue from the acute and 
recovery phases of  NEC were collected, prepared, 
and scored. Intestinal tissue from the acute­phase 
in which severe coagulative necrosis was observed 
histologically was given a score of  3 (Figure 1A). The 
appearance of  the intestinal tissues from the recovery 
phase was normal, and given a score of  0. The extent of  
macrophage infiltration in acute-phase intestinal tissues 
was greater than that in the recovery­phase tissues. To 
determine the potential causal immunological factors, 
we studied the expression of  key signaling components 
that are mediated by LPS activation. The protein levels 
of  NF­κB p65 and TNF­α (Figure 1B) in acute­phase 
intestinal tissues were significantly higher than those in 
recovery­phase tissues. Furthermore, the gene transcript 
levels of  CD14 and MD-2 (Figure 1C) were significantly 
increased in the acute­phase tissues, when compared 
to those in recovery­phase tissues. The TLR4 mRNA 
level was also higher in the acute­phase tissues than in 
the recovery­phase tissues, but this increase was not 
significant statistically.
Molecular pathogenesis of experimental NEC
Rat jejunal histology: Compared to the sham­operated 
control specimens (Figure 2A), there was no apparent 
histological damage (score 0) in jejunal loops that were 
treated with LPS alone (Figure 2B) or distended with 
normal saline (Figure 2C). We observed histological 
changes (Figure 2D) (score 2), such as sloughing of  
the villi and vascular congestion in jejunal specimens 
from rats that were treated with a combination of  saline 
distension and bacterial LPS. Although the changes were 
less severe, they did resemble those that were observed in 
acute­phase intestinal specimens from NEC patients, and 
were associated with substantial macrophage infiltration 
(Figure 3A­D). 
Jejunal distension requires bacterial LPS to trigger 
inf lammatory reactions: To determine whether 
the inflammatory responses could be induced in the 
experimental NEC model, we assessed the key LPS­
mediated signaling components or reporters (CD14, TLR4, 
MD­2, TNF­α and IL­6) at the transcript or protein level 
in the jejunal segments and plasma from each experimental 
group. The results were consistent with the histological 
findings. Combination treatment of  intestinal distension 
and bacterial LPS jejunal injection significantly raised the 
level of  CD14, TLR4 and MD­2 mRNA (P < 0.05) when 
compared to those in saline­distended jejunal tissues, those 
following jejunal distension alone and LPS jejunal injection 
alone, or those from the sham­operated controls (Figure 4). 
We then measured the systemic cytokine responses in 
the experimental NEC animals by ELISA. The serum 
TNF­α and IL­6 levels in the combined distension + LPS 
group were 3­4 times higher than those of  the other single 
treatment groups (distension or LPS jejunal injection alone) 
and the sham­operated control rats (Figure 5A and B).
Therapeutic potential of CD14/CD18 blockage in NEC 
inflammatory response
We tested the therapeutic efficacy of  CD14 or CD18 
blockade in the established rat NEC model by using a 
CD14­neutralizing monoclonal antibody (M­20) as an 
antagonist, and a novel LPS­neutralizing peptide, CD18 
βA peptide, which have been shown to neutralize the 
biological activity of  endotoxin. Treatment with M­20 
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(Figure 2E) or LPS­neutralizing peptide (Figure 2F) 
restored the jejunal microarchitecture to near normal 
(score 0), and attenuated the increased extent of  
macrophage infi ltration in those loops that was 
distended with LPS­containing saline, and contained 
either an antibody against CD 14 (Figure 3E) or LPS­
neutralizing peptide (Figure 3F). This was a sharp 
contrast to the jejunal distension that was caused by LPS­
containing saline (Figures 2D and 3D), which caused 
marked histological changes such as villous sloughing 
and destruction. These histological changes were 
accompanied by concomitant changes in the expression 
levels of  CD14, MD­2 and TLR4 mRNA (Figure 4), and 
the serum levels of  TNF­α and IL­6 (Figure 5).
DISCUSSION
We investigated the role of  innate immunity in the 
pathogenesis of  NEC by examining the LPS/CD14/
TLR4­mediated inflammatory response in jejunal 
tissues from premature neonates with NEC. Using our 
recently established rat NEC model, we demonstrated 
that disease development requires intestinal bowel 
distension and bacterial LPS stimulation. In the human 
NEC tissues, increases in NF­κB p65 and TNF­α and 
mRNA for CD14, TLR4 and MD­2 were found. All 
these signaling­cascade increases were also noted in the 
intestine of  the rat NEC model, with a parallel increase 
in serum TNFα and IL­6. Histologically, changes in 
the LPS­distended rat bowel and human NEC tissue 
were similar. Furthermore, we showed in this model 
that the consequent pro­inflammatory reactions could 
be suppressed or modulated by blocking endotoxin 
activity using a monoclonal CD14 antibody, and a CD18 
βA peptide that neutralizes LPS binding and inhibits 
leukocyte infiltration into inflamed tissues. From these 
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Figure 1  Pathological features of human necrotizing enterocolitis (NEC). A: Representative micrographs that show the microarchitecture of (upper panel), and 
the extent of macrophage infiltration (as marked by arrow) (lower panel) in jejunal tissues from NEC patients, which were collected in the acute phase and during 
recovery. Magnification × 200; B: Immunoblotting showed overexpression of TNF-α and upregulated nuclear content of the p65 subunit of NF-κB in jejunal tissues 
from NEC patients in the acute phase. Nuclear histone level was used as the loading control; C: Real-time PCR detected the mRNA transcript levels of CD14, TLR4 
and MD-2 in jejunal tissues from NEC patients in the acute phase and during recovery. Statistical significance was determined by Student's t test, and all data are 
presented as the mean ± SD of triplicate samples from two independent experiments.
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results, we concluded that each molecule may have 
therapeutic potential for treating infants with NEC. 
The essential role of  the innate TLR4 immunity 
has been reported in a recent study in which TLR4­
A B C
D E F
Figure 2  Histological features of rat jejunum. The severity of damage in the jejunum of rats from the different treatment groups was assessed histologically after 
HE staining. A: Sham-operated controls; B: LPS jejunal injection; C: Saline jejunal distension; D: Saline jejunal distension and LPS jejunal injection; E: Saline jejunal 
distension and LPS jejunal injection, and CD14 antibody treatment; F: Saline jejunal distension and LPS jejunal injection, and LPS-neutralizing peptide treatment. Only 
in (D) did the jejunal tissue show histological changes with a score of 2 for NEC (sloughing of villi and vascular congestion). Magnification × 200. 
A B C
D E F
Figure 3  Macrophage infiltration into the rat jejunum. The extent of macrophage infiltration into the jejunum of rats from the different treatment groups was 
evaluated by immunohistochemistry using a macrophage staining reagent. Stained macrophages are marked by arrows. A: Sham-operated control; B: LPS jejunal 
injection; C: Saline jejunal distension; D: Saline jejunal distension and LPS jejunal injection; E: Saline jejunal distension and LPS jejunal injection, and CD14 antibody 
treatment; F: Saline jejunal distension and LPS jejunal injection, and LPS-neutralizing peptide treatment. Magnification × 200.
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mutant C3H/HeJ mice were protected from developing 
NEC[23]. The f indings in our study suppor t this 
essential role. We demonstrated that the activity of  the 
TLR4 signaling pathway was upregulated in intestinal 
tissues from premature neonates with NEC. Given 
that TLR4 is the major receptor for bacterial LPS on 
immune and some epithelial cells, as well as endothelial 
cells, we examined whether activation of  the TLR4 
signaling pathway occurred in the intestine of  rats with 
experimentally induced NEC. In this model, we injected 
or infused bacterial LPS into a jejunal segment because 
the jejunum, unlike the ileum and colon, is less likely to 
be contaminated by resident bacteria. By choosing this 
segment, we assumed that we would have better control 
over the bacterial LPS concentration in our investigation. 
We studied also the effect of  bowel distension on the 
pathogenesis of  NEC, because intestinal distension as a 
result of  overfeeding is one of  the many risk factors for 
NEC. 
One­month­old rats were chosen for the study 
because, in our previous study[17], the typical NEC 
histological pictures in the intestine could be seen 
when the correct distension pressure and bacterial 
concentration were used. Further, these rats are more 
stable and can avoid changes caused by operative risks 
such as hypotension and hypothermia. NEC also occurs 
in full­term and older infants, and these infants have 
been found to have higher congenital heart diseases that 
also can cause hypoxia[24]. 
Our data showed that bowel distension with saline 
or LPS injection alone could not induce significant 
inflammatory responses in rat jejunal segments. In 
contrast, bowel distension with saline that contained 
bacterial LPS induced substantial release of  TNF­α 
and IL­6 into the serum, and increased the expressions 
of  the LPS receptor and co­receptor mRNAs, and 
the extent of  leukocyte infiltration into the jejunal 
mucosa. These findings suggest that bowel distension in 
overfed premature neonates is capable of  potentiating 
LPS action on innate TLR4 immunity. The underlying 
mechanism by which bowel distension potentiates the 
action of  LPS was not studied here. However, we believe 
that bowel distension injures the intestinal mucosa, and 
exposes the enterocytes to bacterial LPS. The hypoxic 
environment that is induced by bowel distension might 
also participate in this process by upregulating TNF­α 
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production from inflammatory macrophages[24]. 
Perhaps more importantly, our results identified a 
monoclonal CD14 neutralizing antibody and an LPS­
neutralizing peptide as potential therapeutic agents for 
use in NEC. We showed that both molecules could 
suppress the inflammatory response that was induced 
by bowel distension and bacterial LPS. This provides 
additional evidence for the critical role of  innate TLR4 
immunity in the pathogenesis of  NEC. Moreover, our 
findings suggest that antagonism against members 
of  the LPS signaling pathway could be beneficial 
therapeutically in the treatment of  NEC. Given that the 
current management of  premature neonates with NEC 
is still challenging, our novel molecules for treating NEC 
are of  potential therapeutic importance. 
In conclusion, our results suggest that bowel 
distension from overfeeding in premature neonates 
damages the intestinal mucosa. This resultant injury 
potentiates the action of  bacterial LPS on enterocytes 
and resident immune cells, and triggers an immunological 
cascade that results in the development of  NEC. In 
addition, we have shown that antagonistic molecules 
that target key members of  this cascade can be used as 
potential therapeutic agents for treating infants with NEC. 
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Background
Neonatal necrotizing enterocolitis (NEC) is a disease that affects mainly 
premature babies and its mortality and morbidity remain high. The pathogenesis 
of the disease is still not known and preventive measures have not been agreed 
upon. Its treatment is still difficult.
Research frontiers
Bacteria are required for the development of NEC. Since there are no bacteria 
in utero, there is no NEC in fetuses. At present, there is no single bacterium that 
has been identified to cause NEC. Many clinical studies have shown that premature 
babies with overfeeding or feed intolerance have a higher incidence of NEC. 
However, the mechanism by which feeding problems cause NEC is still unknown. 
Innovations and breakthroughs
In many other studies, it has been shown that, in NEC tissue and patient serum, 
there is a marked increase in the pro-inflammatory cytokine profile, although 
again, the cause is unknown. In the present study, human NEC tissue showed 
increased levels of nuclear factor (NF)-κB p65, tumor necrosis factor (TNF)-α, 
and CD14, toll-like receptor 4 (TLR4) and myeloid differentiation protein (MD)-2 
mRNA. Bowel distension is common in overfed and feed-intolerant babies. 
In the present rat model used to mimic this condition, the intestine distended 
with lipopolysaccharide (LPS) showed increased mRNA for CD14, TLR4 and 
MD-2. Also, the rat serum showed raised TNF-α and IL6. Furthermore, the 
intestinal tissue in the rat after distension with LPS showed the typical features 
of NEC with villous sloughing and vascular congestion. These changes could 
be suppressed by blocking the endotoxin activity using a monoclonal CD14 
antibody or a CD18 peptide that neutralized LPS binding and thus inhibited 
leukocyte infiltration into the inflamed tissue.
Applications
This study provides evidence that NEC can be caused by bowel distension 
with bacterial LPS, which is common in overfeeding and feed intolerance. The 
process can be prevented by applying a carefully controlled feeding regimen to 
premature babies. Early detection and stoppage of feeding in the feed-intolerant 
babies can prevent the activation of the cytokine cascade pathway of the LPS 
and TLR4. In babies who have developed NEC, anti-CD14 antibody and CD18 
neutralizing peptide can be a potential strategy to block the LPS activation 
pathway and prevention of leukocyte infiltration.
Terminology
TLRs are transmembrane molecules that help the immune system to recognize 
pathogens, and TLR4 is among the one that sensitizes immune cells to 
bacterial LPS. When stimulated by bacterial LPS, many intracellular signaling 
pathways are activated and lead to the generation of a cascade of pro-
inflammatory cytokine production and release.
Peer review
It should be emphasized that this rat model of NEC resembles the phenotype of 
human NEC. Therefore, further studies may be needed to prove whether there 
is a correlation between the pathogenesis and possible treatment in the rat and 
human models.
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